Solution phase routes for WNT hexapeptides
US-11970551-B2 · Apr 30, 2024 · US
Tetrapeptides
Tetrapeptides · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K5/10 |
| Official title | Tetrapeptides |
| Display label | Tetrapeptides |
| Total patents | 268 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 26 |
| 2016 | 26 |
| 2017 | 29 |
| 2018 | 27 |
| 2019 | 26 |
| 2020 | 33 |
| 2021 | 23 |
| 2022 | 24 |
| 2023 | 17 |
| 2024 | 17 |
| 2025 | 17 |
| 2026 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Peptide analogs of alpha-melanocyte stimulating hormone
US-2017313756-A1 · Nov 2, 2017 · US
Methods And Compositions For Stimulating Collagen Synthesis In Skin Cells
US-2017231890-A1 · Aug 17, 2017 · US
Glycopeptide for contrast agent targeting cancer cells and contrast agent kit containing the same
US-2017216460-A1 · Aug 3, 2017 · US
Conjugates for treating diseases caused by PSMA expressing cells
US-9636413-B2 · May 2, 2017 · US
Composition comprising peptide derived from adiponectin
US-9624286-B2 · Apr 18, 2017 · US
IGF-I poly (ethylene glycol) conjugates
US-9587006-B2 · Mar 7, 2017 · US
Crystal forms
US-9561181-B2 · Feb 7, 2017 · US
Substrate-mimetic akt inhibitor
US-2016369247-A1 · Dec 22, 2016 · US
Conjugates for treating diseases caused by psma expressing cells
US-2016361433-A1 · Dec 15, 2016 · US
Methods and compositions for preventing or treating ophthalmic conditions
US-2016361377-A1 · Dec 15, 2016 · US
Conjugates for treating diseases caused by psma expressing cells
US-2016361376-A1 · Dec 15, 2016 · US
Conjugates for treating diseases caused by psma expressing cells
US-2016361432-A1 · Dec 15, 2016 · US
Pro-angiogenic peptides and peptide conjugates
US-2016333070-A1 · Nov 17, 2016 · US
Substrate-mimetic Akt inhibitor
US-9453049-B2 · Sep 27, 2016 · US
Tubulysin compounds, methods of making and use
US-2016264624-A1 · Sep 15, 2016 · US
Micropeptides and use of same for modulating gene expression
US-2016251402-A1 · Sep 1, 2016 · US
Pharmaceutical Compositions of Growth Hormone Secretagogue Receptor Ligands
US-2016220637-A1 · Aug 4, 2016 · US
Composition comprising peptide derived from adiponectin
US-2016222077-A1 · Aug 4, 2016 · US
Crystal forms
US-2016220487-A1 · Aug 4, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K5/10?
- CPC C07K5/10 is the Cooperative Patent Classification code for “Tetrapeptides.”
- How many patents are filed under CPC C07K5/10 (Tetrapeptides)?
- Our database includes 268 publications tagged with this CPC code.
- Is patent activity under CPC C07K5/10 growing?
- Publication counts under this code: 17 in 2024 vs 17 in 2025 (latest complete years).